Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2018-01, Vol.59 (1), p.221-224
Main Authors: Pianko, Matthew J., Funt, Samuel A., Page, David B., Cattry, Deepika, Scott, Emma C., Ansell, Stephen M., Borrello, Ivan M., Gutierrez, Martin, Lendvai, Nikoletta, Hassoun, Hani, Landgren, C. Ola, Lesokhin, Alexander M.
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological - adverse effects
Antineoplastic Agents, Immunological - therapeutic use
Combined Modality Therapy - methods
Female
Humans
Male
Middle Aged
Multiple Myeloma - drug therapy
Multiple Myeloma - pathology
Neoplasm Recurrence, Local
Nivolumab - adverse effects
Nivolumab - therapeutic use
Remission Induction
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.1080/10428194.2017.1320713